How The Neuronetics (STIM) Investment Story Is Reset As Analysts Rework Valuation Assumptions [Yahoo! Finance]
Neuronetics, Inc. (STIM)
Last neuronetics, inc. earnings: 3/3 06:00 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
Neuronetics' latest analyst update keeps the fair value price target unchanged at US$4.33, signaling that the core valuation view is intact for now. Bullish and bearish analysts are reading that steady figure very differently, using it to support opposing views on risk, sentiment, and how expectations for the stock are being reset. As you read on, you will see how to track these shifting narratives and what they might mean for your own research on Neuronetics. Stay updated as the Fair Value for Neuronetics shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on Neuronetics. What Wall Street Has Been Saying ?? Bullish Takeaways Some readers may view Canaccord's revised work as a sign that analysts are still engaged with Neuronetics' story, updating their models rather than dropping coverage. This can be useful if you rely on external research as a reference point. The presence of a detailed price target framew
Show less
Read more
Impact Snapshot
Event Time:
STIM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
STIM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
STIM alerts
High impacting Neuronetics, Inc. news events
Weekly update
A roundup of the hottest topics
STIM
News
- Neuronetics (STIM) was upgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=STIM&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "sell" to "hoMarketBeat
- Optum/United Healthcare/United Behavioral Health Expands NeuroStar® TMS Coverage to Include Psychiatric Mental Health Nurse PractitionersGlobeNewswire
- Neuronetics Comments on Letter from Pointillist Family OfficeGlobeNewswire
- Largest Independent Shareholder of Neuronetics, Inc., Jorey Chernett, Calls for Immediate and Comprehensive Review of Strategic Alternatives, Including Sale of TMS Business [Yahoo! Finance]Yahoo! Finance
- Neuronetics Announces Chief Financial Officer Transition [Yahoo! Finance]Yahoo! Finance
STIM
Earnings
- 3/17/26 - Beat
STIM
Analyst Actions
- 3/19/26 - Canaccord Genuity
STIM
Sec Filings
- 4/13/26 - Form EFFECT
- 4/9/26 - Form DEFA14A
- 4/9/26 - Form DEF
- STIM's page on the SEC website